November is known throughout the world as the month of awareness and prevention of prostate cancer, and the November Blue Campaign reinforces attention to the risks of the disease and the incentive for routine testing.
According to the Ministry of Health, prostate cancer ranks second in the ranking of the most common diseases among men, just behind skin cancer.
In addition to testing and recommended treatment, maintaining regular sleep can also help in combating this type of cancer.
Melatonin, known as the hormone regulating sleep, has the potential to slow the growth of tumors. The material acts in control of the formation of new blood vessels from the already existing blood vessels of the tumor, a process called angiogenesis.
According to Renata Federighi, a sleep counselor for Duoflex, melatonin is produced naturally in response to lack of lighting, responsible for informing the body that it is at bedtime. "It is essential that people sleep without interruption of light so as not to interfere with their production and harm their health," he explains.
During the night, the cells need to rest completely in order not to lose efficiency and suffer mutations, which can be the cause of the appearance of cancer. "A few hours sleep also weaken the immune system and promote inflammatory conditions, leaving the body more vulnerable to tumors," adds Renata.
Harvard on prostate cancer
A study conducted by Harvard University in the United States noted that satisfactory levels of melatonin can reduce the risk of prostate cancer. They tested 928 men, those who showed high levels of the hormone, the probability of developing the disease that was 75% lower.
The expert gives some tips for quality sleep and correct repair of body functions. "It is important to pay attention to the posture, use a pillow that offers comfort and support in the head and straightens the spine, keeping the environment as cool and quiet and dark as possible, eating healthy and preventing irritation before bedtime," concludes a dream consultant.